Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, with the page header and footer still visible and a Home link present. This indicates access to the study view is blocked rather than updated study details being shown.
    Difference
    0.5%
    Check dated 2026-09-27T22:07:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page is displaying a 403 Forbidden error, replacing the study details and documents with a generic header and footer. This view prevents access to the study content and related documents.
    Difference
    17%
    Check dated 2026-09-20T20:40:58.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Israel study locations updated: Tel Litwinsky (52621) added and Qiryat Krinitzi (52621) removed. This changes the pool of active enrollment sites for the trial in Israel.
    Difference
    0.1%
    Check dated 2026-09-13T21:56:56.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new trial site in Qiryat Krinitzi, Israel (52621) has been added to the study locations, and the Tel Litwinsky, Israel site (52621) has been removed. This updates the geographic footprint of the study in Israel and may affect where participants can enroll.
    Difference
    0.1%
    Check dated 2026-09-06T22:33:34.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a minor patch; no study details or page content are affected.
    Difference
    0.0%
    Check dated 2026-08-30T22:23:50.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record page now renders an error indicating the content is unavailable, preventing loading of the NALA study details. A large set of study documents and materials (e.g., PDFs, SAP, protocol) have been removed from the page.
    Difference
    15%
    Check dated 2026-08-09T12:00:19.000Z thumbnail image

Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.